Merck’s ex-official appointed as new R&D head for Johnson & Johnson, Pharma giant opens door for further M&As
Category: #health  By Saipriya Iyer  Date: 2017-06-12
  • share
  • Twitter
  • Facebook
  • LinkedIn

Merck’s ex-official appointed as new R&D head for Johnson & Johnson, Pharma giant opens door for further M&As

Johnson & Johnson, Inc., one of the most reputed and popular companies operating in global pharmaceutical market, has appointed a new head - Mathai Mammen, for its research & development wing, as a part of its routine organization restructuring program. Preceding this appointment was former R&D head William Hait’s appointment as global head, J&J external innovation. Through this position, Hait aims to oversee Johnson & Johnson’s partnering portfolio, replete with numerous agreement with reputed companies all over the globe.

As per reports, Hait had already catapulted the pharma giant to a profitable position across the globe, by means of enabling lucrative partnerships and collaborations. This restructuring, say company insiders, will only serve to be highly fruitful to the organization from the business point of view. For one, Hait’s appointment as global head, J&J external innovation has entrusted him with the responsibility of the firm’s JLABS startup incubators, JJDC VC wing, and the innovation centers J&J has set up in MA, London, CA, Boston, Menlo Park, Shanghai, and United Kingdom. Hait’s decade long experience as R&D head is expected to serve him well and do justice to his new posting. The company aims to attract an extensive number of investors and strengthen their global network.

Hait’s arrival at Johnson & Johnson as the head of R&D for the hematology and oncology disciplines 10 years earlier was marred by the company’s efforts to consolidate the teams working across numerous units of aforementioned therapeutic areas. Hait however, oversaw the research with diligence and as reports have it, he successfully established J&J as a force to reckon with, by means of commercializing drugs such as Darzalex, the first monoclonal antibody that was approved by the FDA to be used in the treatment of multiple myeloma.

Mathai Mammen, one of the most prominent ex-executives of Merck, and the co-founder of Theravance Biopharma, the reputed biopharmaceutical company headquartered in San Francisco, has had an impressive record in R&D, possibly owing to which he had been lured away by J&J as the new R&D head. Mammen’s experience as a senior Vice-President in Theravance and as a senior position of R&D in Merck will help catapult Johnson & Johnson to greater heights, given that Hait has already provided Mammen with a pipeline that he reportedly mentioned was one of the most sustainable and robust ones in the industry.

This restructuring is anticipated to bring in renewed growth prospects for J&J. With Hait already having established a pipeline of lucrative mergers, Mammen’s profile has apparently turned more challenging, for which the eminent ex-Merck-executive will have to ante up his performance level and jelp Johnson & Johnson achieve its recently set targets for sales growth and new approvals.



About Author

Saipriya Iyer

Email: [email protected]   

Saipriya Iyer

Saipriya Iyer develops content for Market Size Forecasters, Algosonline, and myriad other platforms. A computer engineer by profession, she ventured into the field of writing for the love of playing with words. Having had a previous experience of 3 years under her bel...

Read More

More News By Saipriya Iyer

Vela Diagnostics gains EUA for ViroKey™ SARS-CoV-2 RT-PCR test v2.0
Vela Diagnostics gains EUA for ViroKey™ SARS-CoV-2 RT-PCR test v2.0
By Saipriya Iyer

Vela Diagnostics has recently announced that the U.S. FDA has granted an EUA (Emergency Use Authorization) for its ViroKey™ SARS-CoV-2 RT-PCR Test v2.0 in the United States. This automated p...

Foodics enters Egypt market by setting an on-ground presence in Cairo
Foodics enters Egypt market by setting an on-ground presence in Cairo
By Saipriya Iyer

Saudi Arabia-based restaurant management platform Foodics, has announced that it has entered the Egyptian market by creating an on-the-ground presence in Cairo.  The expansion comes after the company raised USD 4 ...

Food Emulsifiers Market to Witness an Appreciable Growth By 2026
Food Emulsifiers Market to Witness an Appreciable Growth By 2026
By Saipriya Iyer

This advanced report on the Food Emulsifiers Market includes of an in-depth overview of this business sphere. Alongside, details of the present market size and status have been given. The report aims to provide substantial updates on the market, p...